Director, Cell Therapy WW Medical Affairs, Multiple Myeloma and Solid Tumor Pipeline

About this role

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us .

Position Overview

At BMS, we are committed to the advancement of science with the drive to improve every day for the benefit of patients. To accelerate our position as leaders in cell therapy and serve patients around the world, we are committed to being at the forefront of change. Reporting to the ED, CT MM/Solid Tumor Pipeline Lead, the Director, MM and Solid Tumor Pipeline will represent WW Medical Affairs as therapeutic area expert and provide scientific leadership and support for CAR T compounds in various stages of clinical development.

Key Responsibilities • Strategic Leadership of Multiple Myeloma and Solid Tumor Assets • Lead cross-functional initiatives related to Multiple Myeloma and/or Solid Tumor pipeline assets, integrating strategies across different therapeutic areas where necessary.

• Collaborate with local medical affairs teams to align on disease strategy and tactics, ensuring cohesive action plans.

• Develop strategic plans for cell therapy entry into Solid Tumor, including shaping of early asset medical strategy and providing medical input to overall early asset portfolio

• Drive cross-asset collaboration and knowledge sharing, fostering a unified BMS presence in Multiple Myeloma (MM) and Solid Tumors, including partnerships across Cell Therapy and Oncology.

• Establish and cultivate relationships with thought leaders in the field.

• Seamless Execution of Core Medical Affairs Deliverables • Provide strategic input to guide publication planning and execution; serve as key reviewer and feedback provider on abstracts, presentations, and publications as required

• Develop and implement congress strategies to achieve impactful presence and engagement.

• Organize BMS-sponsored symposia at congresses such as COMy, EHA, and IMS, to enhance scientific dialogue.

• Refine Integrated Evidence Plan (IEP) to ensure alignment with strategic goals.

• Conduct comprehensive reviews of publications and update key launchpad assets, including slide decks, training sessions, and Q&A materials.

• Lead and support the execution of global advisory boards and strategic committee meetings and assist regional teams with globally impactful advisory initiatives.

• Provide medical perspective on evidence generation, including expert review and recommendations for new ISR and CRC trials as well as HEOR analyses.

• Ensure scientific excellence in medical education and effective data exchange.

• Provide Scientific/Medical Expertise Across the Matrix • Offer medical insights to guide clinical development plans and influence strategic decision-making processes for both early and late development

• Serve as subject matter expert to cross-functional partners: • In Multiple Myeloma to guide decision-making at both the asset and portfolio level

• Across solid tumors to shape development and strategy for early assets, beginning with RCC

• Collaborate with global and local market access and marketing teams, providing expert medical content to support initiatives.

• Work collaboratively with patient advocacy to align objectives and enhance engagement.

Qualifications & Experience • Advanced Medical/Biology degree (MD, PhD, PharmD) with clinical and/or 6-8 years of Pharma industry experience required

• Knowledge of CAR-T therapy and Multiple Myeloma preferred, but not required 

• Familiarity with clinical and translational research activities

• Highly organized, efficient, and motivated individual with the ability to lead multiple projects and initiatives across matrix teams

• Excellent verbal & written communication skills, including presentations to large groups, senior leadership, facilitation of interactive discussions, and 1:1 discussions with thought leaders

• Proven agility in prioritizing and navigating competing demands

• Strategic Thinking: Demonstrated strength in understanding overarching company goals, performing strategic assessments, and developing clearly framed choices and recommendations. Proven record of managing complex interactions that drive business strategy & priorities engaging both internal and external stakeholders.

• Cross-Functional Experience: Experience working across a range of medical and/or clinical development roles is a plus. Highly collaborative, possess a record of building and maintaining cross-functional relationships, and able to communicate business topics effectively with senior leadership, peers, and others.

• Interpersonal Skills: Ability to build relationships, influence, and drive organizational engagement at all levels.

• Leadership: Ability to lead strategically, drive performance, build alignment, negotiate, and collaborate.

• Estimated 15-20% US and global travel (as applicable)

Additional Locations: Boudry, Switzerland

#LI-HYBRID

If you come across a role that intrigues you but doesn’t perfectly line up with your resume, we encourage you to apply anyway. You could be one step away from work that will transform your life and career.

Compensation Overview:

Madison - Giralda - NJ - US: $207,490 - $251,433
Princeton - NJ - US:

Similar jobs

• Director, Global Commercial, Cell Therapy, Multiple Myeloma — Bristol Myers Squibb · Princeton, NJ | Madison, Giralda, NJ
• Executive Director, Global Medical Affairs Disease Area Lead, Solid Tumors — BeiGene · Remote
• Executive Director, Regional Medical Lead - Solid Tumors, Medical Affairs, Europe — BeiGene · Remote
• Associate Director, Process Development, Cell Therapy — AstraZeneca · US – Santa Monica Colorado Avenue – CA
• Senior Medical Director, Clinical Development, Hematology, Nephrology, & Transplant, Cell Therapy — AstraZeneca · MA, Boston
• Director, Global Value, Access & Pricing; Solid Tumors, Pipeline — BeiGene · Remote
• Associate Director, Cell Therapy Territory Operations Manager — AstraZeneca · MA, Boston
• Director, Medical Affairs, Hemato-Oncology, Europe — BeiGene · Remote